Scholars@Duke publication: Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.

Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.

Publication , Journal Article

Henson, JB; Corey, KE

Published in: Alimentary pharmacology & therapeutics

May 2020

Published version (DOI)

Duke Scholars

Author Jackie Henson

Published In

Alimentary pharmacology & therapeutics

DOI

10.1111/apt.15696

EISSN

1365-2036

ISSN

0269-2813

Publication Date

May 2020

Volume

Issue

Start / End Page

988 / 989

Related Subject Headings

Risk Factors
Non-alcoholic Fatty Liver Disease
Liver Cirrhosis
Humans
Gastroenterology & Hepatology
Fibrosis
Cardiovascular Diseases
3214 Pharmacology and pharmaceutical sciences
3202 Clinical sciences
1115 Pharmacology and Pharmaceutical Sciences

Citation

APA

Chicago

ICMJE

MLA

NLM

Henson, J. B., & Corey, K. E. (2020). Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply. Alimentary Pharmacology & Therapeutics, 51(10), 988–989. https://doi.org/10.1111/apt.15696

Henson, Jacqueline B., and Kathleen E. Corey. “Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.” Alimentary Pharmacology & Therapeutics 51, no. 10 (May 2020): 988–89. https://doi.org/10.1111/apt.15696.

Henson JB, Corey KE. Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply. Alimentary pharmacology & therapeutics. 2020 May;51(10):988–9.

Henson, Jacqueline B., and Kathleen E. Corey. “Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.” Alimentary Pharmacology & Therapeutics, vol. 51, no. 10, May 2020, pp. 988–89. Epmc, doi:10.1111/apt.15696.

Henson JB, Corey KE. Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply. Alimentary pharmacology & therapeutics. 2020 May;51(10):988–989.

Published In

Alimentary pharmacology & therapeutics

DOI

10.1111/apt.15696

EISSN

1365-2036

ISSN

0269-2813

Publication Date

May 2020

Volume

Issue

Start / End Page

988 / 989

Related Subject Headings

Risk Factors
Non-alcoholic Fatty Liver Disease
Liver Cirrhosis
Humans
Gastroenterology & Hepatology
Fibrosis
Cardiovascular Diseases
3214 Pharmacology and pharmaceutical sciences
3202 Clinical sciences
1115 Pharmacology and Pharmaceutical Sciences